治疗脑麻儿童睡眠障碍的口服メラトニン补充剂:一项随机双盲对照试验
Gire Pooja K1, Smita Mundada2, Janhavi Zambani3
1Consultant Pediatric Intensivist, Manipal Hospitals Pvt Ltd, Pune, Maharashtra, India.
Indian journal of pediatrics
|December 10, 2025
概括
口服的黑激素有效地改善了脑 (CP) 的儿童的睡眠. 这种治疗显著减少睡眠开始的延迟,并增加总睡眠时间,副作用最小.
科学领域:
- 儿科神经学 儿科神经学
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有脑性麻 (CP) 的儿童常有睡眠问题.
- 非药物疗法对于与CP相关的睡眠障碍往往是不够的.
研究的目的:
- 评估口服黑激素治疗CP儿童睡眠问题的疗效和安全性.
- 为了确定黑激素对睡眠开始延迟和总睡眠时间的影响.
主要方法:
- 一项为期12周的随机,双盲,安慰剂对照试验,涉及120名患有CP和睡眠问题的儿童 (3-12岁).
- 参与者每天接受口服黑激素 (3-10毫克) 或安慰剂.
- 睡眠测量包括儿童睡眠障碍量表 (SDSC) 和照顾者报告的睡眠日记.
主要成果:
- 黑色素显著减少了4周和12周的睡眠开始延迟 (P < 0.001).
- 在4周和12周的黑色素治疗中,总睡眠时间显著增加 (P < 0.001).
- 黑色素耐受性很好,报告的副作用很小.
结论:
- 口服黑激素 (每天3-10毫克) 是一种有效的治疗方法,可以减少CP儿童的睡眠开始延迟.
- 黑色素显著改善了这一群体的总睡眠时间.
- 该疗法表现出良好的安全性,副作用最小.
相关概念视频
Management of Insomnia
495
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
495
Sedatives and Hypnotics Drugs: Miscellaneous Agents
470
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
470


